ESCRS NEWS


Colin Kerr
Published: Tuesday, February 9, 2016
SUPPORTING ORBIS
The ESCRS is supporting a new Orbis initiative to strengthen a network of medical schools and training across six countries in East Africa.
This enterprise will address the gaps currently felt across eye healthcare systems in the region and look at ways to build an African-owned leadership network of skilled ophthalmic trainers. This group will be able to improve training opportunities for medical professionals within their own countries, thus increasing the number of highly trained eye care specialists. This initiative is part of the ongoing ESCRS support for Orbis and Oxfam. Details of the Oxfam project will be announced in the next edition of ESCRS News.
ESCRS LAUNCHES NEW LOGO
"There is nothing permanent except change." Heraclitus of Greece, circa 470BC
The ESCRS has a new logo which is now being displayed on all ESCRS literature, conference signage and on our website. So why the new look? At the ESCRS, evolution is at our core. The evolution of surgical procedures and treatments is the direct result of research and of ophthalmologists teaching and learning from each other. Our identity must reflect our changing world and the global membership that we represent. We have thought about our society and what it means to you, our members and ophthalmologists who attend our conferences.We believe our new logo will reflect our identity and the evolution of the ESCRS in the coming years.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.